Stockwell Lynn (CIK 1927032) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-01). Recent activity: Buy DMII (700,000 shares), Sell DMII (400,000 shares), Sell DMII (8.0M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-01 | Drugs Made In America Acquisition II Corp. (DMII) | CEO and Exe. Chair of Board | Buy | 700,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II Corp. (DMII) | CEO and Exe. Chair of Board | Sell | 400,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II Corp. (DMII) | CEO and Exe. Chair of Board | Sell | 8.0M | $0 |
Source: SEC Form 4 filings · as of 2025-10-01